Los Altos, CA (PRWEB) June 07, 2022 Afero, a leading provider of secure Internet of Things (“IoT”) platform-as-a-service solutions, will be exhibiting at
Therma Bright Inc : Therma Bright Finalizes Agreement with Afero for Its Smart-Enabled AcuVid Saliva Test finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Afero partners with Therma Bright to make AcuVid™ COVID-19 Rapid Antigen Saliva Test smart-enabled
Share Article
Silicon Valley tech firm brings encrypted solution for tracking Canadian developer’s 15-minute Covid19 rapid antigen test for point of care, and then at-home testing LOS ALTOS, Calif. (PRWEB) April 28, 2021 Afero has entered into an agreement with Therma Bright TSXV(THRM.V), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, to bring greater innovation, security and tracking to its 15-minute COVID-19 rapid antigen screening solution. AcuVid™, Powered by Afero, will help communities safely and securely return to work and play using embedded and encrypted technology for tracking and reporting AcuVID Tests for quality assurance, shipping, logistics, and point-of-care test results. It also paves the way for preparing the Acu
(2)
Silicon Valley tech firm brings encrypted solution for tracking Canadian developer s 15-minute Covid19 rapid antigen test for point of care, and then at-home testing
Toronto, Ontario (Newsfile Corp. - April 28, 2021) - Afero has entered into a memorandum of understanding (MOU) agreement with Therma Bright Inc. (TSXV: THRM), the Company or Therma Bright ), developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies. The mutually beneficial partnership looks to bring Afero s innovation, security and tracking technology to Therma Bright s 15-minute COVID-19 rapid antigen screening solution. Upon completion, the proposed agreement will offer AcuVid COVID-19 Rapid Antigen Saliva Tests powered by Afero, with a goal to help communities safely and securely return to work and play using an embedded and encrypted technology for tracking and reporting AcuVID Tests for quality assurance, shipping, logistics, and point-of-ca